PMC9251043_01
Age distribution in the study population
41870_2022_973_Fig1_HTML.jpg
PMC9251043_01_41870_2022_973_Fig1_HTML.jpg
Fig1
Figure 1 shows the age distribution in our study population.
Gender domination in the study population
41870_2022_973_Fig2_HTML.jpg
PMC9251043_01_41870_2022_973_Fig2_HTML.jpg
Fig2
February 2020. Figure 2 shows the gender domination in the study population.
Blood group type in the study population
41870_2022_973_Fig3_HTML.jpg
PMC9251043_01_41870_2022_973_Fig3_HTML.jpg
Fig3
Figure 3 shows the blood group in the study population.
Smoker and non-smoker subjects in the study population
41870_2022_973_Fig4_HTML.jpg
PMC9251043_01_41870_2022_973_Fig4_HTML.jpg
Fig4
Figure 4 shows the percentage of smoker and non-smoker subjects in the study population.
Subjects with symptoms in the study population
41870_2022_973_Fig5_HTML.jpg
PMC9251043_01_41870_2022_973_Fig5_HTML.jpg
Fig5
Moreover, most subjects develop symptoms like cough, fever, diarrhea, headache, fatigue, loss of taste and smell while few of them don't develop any symptoms as shown in Fig. 5.
Chronic disease in the study population
41870_2022_973_Fig6_HTML.jpg
PMC9251043_01_41870_2022_973_Fig6_HTML.jpg
Fig6
Figures 6 and 7 show the distribution of chronic disease and multivitamins administration in the study population respectively.
Multivitamins administration in the study population
41870_2022_973_Fig7_HTML.jpg
PMC9251043_01_41870_2022_973_Fig7_HTML.jpg
Fig7
Figures 6 and 7 show the distribution of chronic disease and multivitamins administration in the study population respectively.